Persistent and relapsing babesiosis in immunocompromised patients PJ Krause, BE Gewurz, D Hill, FM Marty, E Vannier, IM Foppa, ... Clinical Infectious Diseases 46 (3), 370-376, 2008 | 350 | 2008 |
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384 GK Robbins, JG Spritzler, ES Chan, DM Asmuth, RT Gandhi, ... Clinical Infectious Diseases 48 (3), 350-361, 2009 | 295 | 2009 |
2′, 3′-didehydro-3′-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial MJ Browne, KH Mayer, SBD Chafee, MN Dudley, MR Posner, ... Journal of Infectious Diseases 167 (1), 21-29, 1993 | 248 | 1993 |
Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections: a phase I and II study TC Merigan, G Skowron, SA Bozzette, D Richman, R Uttamchandani, ... Annals of internal medicine 110 (3), 189-194, 1989 | 246 | 1989 |
2', 3'‐Dideoxycytidine (ddC) toxic neuropathy: A study of 52 patients AR Berger, JC Arezzo, HH Schaumburg, G Skowron, T Merigan, ... Neurology 43 (2), 358-358, 1993 | 228 | 1993 |
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates JM Whitcomb, W Huang, K Limoli, E Paxinos, T Wrin, G Skowron, ... Aids 16 (15), F41-F47, 2002 | 126 | 2002 |
Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach AS De Groot, B Jesdale, W Martin, C Saint Aubin, H Sbai, A Bosma, ... Vaccine 21 (27-30), 4486-4504, 2003 | 118 | 2003 |
Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus DH Schwartz, G Skowron, TC Merigan JAIDS Journal of Acquired Immune Deficiency Syndromes 4 (1), 11-23, 1991 | 98 | 1991 |
Causes of death in persons with human immunodeficiency virus infection M Stein, P O'Sullivan, T Wachtel, A Fisher, D Mikolich, S Sepe, G Fort, ... The American journal of medicine 93 (4), 387-390, 1992 | 94 | 1992 |
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex G Skowron, SA Bozzette, L Lim, CB Pettinelli, HH Schaumburg, J Arezzo, ... Annals of internal medicine 118 (5), 321-330, 1993 | 87 | 1993 |
Preventing transfusion‐transmitted babesiosis: preliminary experience of the first laboratory‐based blood donor screening program C Young, A Chawla, V Berardi, J Padbury, G Skowron, PJ Krause, ... Transfusion 52 (7), 1523-1529, 2012 | 80 | 2012 |
Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cells GK Sahu, K Sango, N Selliah, Q Ma, G Skowron, RP Junghans Virology 446 (1-2), 268-275, 2013 | 77 | 2013 |
Biologic effects and safety of stavudine: overview of phase I and II clinical trials G Skowron Journal of Infectious Diseases 171 (Supplement_2), S113-S117, 1995 | 75 | 1995 |
the ddC Study Group of the AIDS Clinical Trials Group. 1989. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections: a … TC Merigan, G Skowron, SA Bozzette, D Richman, R Uttamchandani, ... Ann. Intern. Med 110, 189-194, 0 | 64 | |
Reanalysis of Coreceptor Tropism in HIV-1–Infected Adults Using a Phenotypic Assay with Enhanced Sensitivity TJ Wilkin, MB Goetz, R Leduc, G Skowron, Z Su, ES Chan, J Heera, ... Clinical infectious diseases 52 (7), 925-928, 2011 | 61 | 2011 |
A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects RC Kalayjian, G Skowron, RT Emgushov, M Chance, SA Spell, PR Borum, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 7 (4), 369-374, 1994 | 54 | 1994 |
Safety and tolerance of dideoxycytidine as a single agent: results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related … TC Merigan, G Skowron The American journal of medicine 88 (5), S11-S15, 1990 | 53 | 1990 |
Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence HIV Trialists' Collaborative Group Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 1999 | 50 | 1999 |
Baseline CD4+ cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy G Skowron, JC Street, EM Obee JAIDS Journal of Acquired Immune Deficiency Syndromes 28 (4), 313-319, 2001 | 44 | 2001 |
Lack of pharmacokinetic interaction between nelfinavir and nevirapine G Skowron, G Leoung, B Kerr, A Dusek, R Anderson, S Beebe, R Grosso Aids 12 (10), 1243-1244, 1998 | 44 | 1998 |